PTGS2 and Cognitive impairment: These observations suggest that COX-2 elevations contribute to neurodegenerative associated synaptic and cognitive impairments and given the resemblance between increased COX-2 expression in our CICI mouse model and neurodegenerative conditions, we explored whether COX-2 inhibition could have therapeutic benefits in CICI.